N
News Analysis
dailypolitical.com

www.dailypolitical.com ·

Positive

Profund Advisors Llc Increases Holdings in Alnylam Pharmaceuticals Inc Alny

Econ PriceChief Executive OfficerExecutive OfficerHistoric

All NewsRead the full story on dailypolitical.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

The article reports institutional investor activity and strong earnings for Alnylam Pharmaceuticals, a biotech firm. The commercial mechanism is weak: no new product, pipeline, or regulatory event is mentioned. The impact is limited to the company's stock and sector sentiment, with no direct supply chain or scarcity implications.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

  • Profund Advisors increased ALNY holdings by 340.9% in Q4, acquiring 12,053 additional shares.
  • Alnylam reported Q1 2026 EPS of $1.99, beating estimates.
  • Revenue was $1.17 billion, up 96.4% year-over-year.
  • Stock price $286.27, market cap $38.22 billion.

About the publisher

dailypolitical.com is one of the en-language news outlets that News Analysis aggregates. Coverage from this source appears in our global feed alongside the publisher's own reporting.

Topic context

dailypolitical.com files this story under "econ price" in the GDELT knowledge graph. News Analysis surfaces coverage based on the same open classification taxonomy.

Profund Advisors Llc Increases Holdings in Alnylam Pharmaceuticals Inc Alny — News Analysis